隐孢子虫特异性 IMP 脱氢酶抑制剂选择性的结构基础。
The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.
机构信息
Departments of Biology, Brandeis University, MS009, 415 South Street, Waltham, Massachusetts 02454, USA.
出版信息
J Am Chem Soc. 2010 Feb 3;132(4):1230-1. doi: 10.1021/ja909947a.
Abstract
Cryptosporidium parvum is a potential biowarfare agent, an important AIDS pathogen, and a major cause of diarrhea and malnutrition. No vaccines or effective drug treatment exist to combat Cryptosporidium infection. This parasite relies on inosine 5'-monophosphate dehydrogenase (IMPDH) to obtain guanine nucleotides, and inhibition of this enzyme blocks parasite proliferation. Here, we report the first crystal structures of CpIMPDH. These structures reveal the structural basis of inhibitor selectivity and suggest a strategy for further optimization. Using this information, we have synthesized low-nanomolar inhibitors that display 10(3) selectivity for the parasite enzyme over human IMPDH2.
摘要
微小隐孢子虫是一种有潜力的生物战剂，一种重要的艾滋病病原体，也是导致腹泻和营养不良的主要原因。目前尚无疫苗或有效药物来对抗隐孢子虫感染。这种寄生虫依赖肌苷 5'-单磷酸脱氢酶（IMPDH）获取鸟嘌呤核苷酸，而抑制这种酶可以阻止寄生虫的增殖。在这里，我们报告了第一个微小隐孢子虫 IMPDH 的晶体结构。这些结构揭示了抑制剂选择性的结构基础，并提出了进一步优化的策略。利用这些信息，我们已经合成了低纳摩尔的抑制剂，对寄生虫酶相对于人 IMPDH2 具有 10(3)的选择性。
相似文献
1
The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.隐孢子虫特异性 IMP 脱氢酶抑制剂选择性的结构基础。
J Am Chem Soc. 2010 Feb 3;132(4):1230-1. doi: 10.1021/ja909947a.
2
Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.微小隐孢子虫肌苷 5′-单磷酸脱氢酶的苯并嗪酮抑制剂。
Bioorg Med Chem Lett. 2013 Feb 15;23(4):1004-7. doi: 10.1016/j.bmcl.2012.12.037. Epub 2012 Dec 27.
3
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.微小隐孢子虫肌苷5'-单磷酸脱氢酶的三唑抑制剂
J Med Chem. 2009 Aug 13;52(15):4623-30. doi: 10.1021/jm900410u.
4
Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.隐孢子虫属微小隐孢子虫 IMPDH 选择性苯并咪唑类抑制剂的构效关系研究。
Bioorg Med Chem Lett. 2012 Mar 1;22(5):1985-8. doi: 10.1016/j.bmcl.2012.01.029. Epub 2012 Jan 24.
5
Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.选择性和有效的隐孢子虫肌苷 5'-单磷酸脱氢酶的尿素抑制剂。
J Med Chem. 2012 Sep 13;55(17):7759-71. doi: 10.1021/jm3007917. Epub 2012 Sep 5.
6
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.作为广谱特异性肌苷 5'-单磷酸脱氢酶（IMPDH）抑制剂的吗啉甲酰胺。
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127543. doi: 10.1016/j.bmcl.2020.127543. Epub 2020 Sep 12.
7
Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.4-氧代-[1]苯并吡喃并[4,3-c]吡唑隐孢子虫肌苷5'-单磷酸脱氢酶（CpIMPDH）抑制剂的合成、体外评价及共晶结构
J Med Chem. 2014 Dec 26;57(24):10544-50. doi: 10.1021/jm501527z. Epub 2014 Dec 4.
8
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.针对真核病原体中的一种原核蛋白：鉴定抗隐孢子虫病的先导化合物。
Chem Biol. 2008 Jan;15(1):70-7. doi: 10.1016/j.chembiol.2007.12.010.
9
Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.优化苯并恶唑类隐孢子虫肌苷 5′-单磷酸脱氢酶抑制剂。
J Med Chem. 2013 May 23;56(10):4028-43. doi: 10.1021/jm400241j. Epub 2013 May 13.
10
Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.P131 隐孢子虫-IMP 脱氢酶选择性的分子基础：结构、动态和机制的观点。
Cell Biochem Biophys. 2021 Mar;79(1):11-24. doi: 10.1007/s12013-020-00950-1. Epub 2020 Oct 15.
引用本文的文献
1
A journey into the regulatory secrets of the purine nucleotide biosynthesis.嘌呤核苷酸生物合成调控奥秘之旅。
Front Pharmacol. 2024 Feb 20;15:1329011. doi: 10.3389/fphar.2024.1329011. eCollection 2024.
2
The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Infections.肌苷 5'-单磷酸脱氢酶的酶活性可能不是感染的易损靶点。
ACS Infect Dis. 2021 Nov 12;7(11):3062-3076. doi: 10.1021/acsinfecdis.1c00342. Epub 2021 Sep 30.
3
A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.一种可能的手段：探索 P131 药效团支架，以鉴定微小隐孢子虫肌苷单磷酸脱氢酶的潜在抑制剂。
J Mol Model. 2021 Jan 9;27(2):35. doi: 10.1007/s00894-020-04663-3.
4
Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.P131 隐孢子虫-IMP 脱氢酶选择性的分子基础：结构、动态和机制的观点。
Cell Biochem Biophys. 2021 Mar;79(1):11-24. doi: 10.1007/s12013-020-00950-1. Epub 2020 Oct 15.
5
Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.作为广谱特异性肌苷 5'-单磷酸脱氢酶（IMPDH）抑制剂的吗啉甲酰胺。
Bioorg Med Chem Lett. 2020 Dec 15;30(24):127543. doi: 10.1016/j.bmcl.2020.127543. Epub 2020 Sep 12.
6
Genetic ablation of purine salvage in reveals nucleotide uptake from the host cell.嘌呤补救途径的遗传消融揭示了从宿主细胞摄取核苷酸。
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21160-21165. doi: 10.1073/pnas.1908239116. Epub 2019 Sep 30.
7
Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.5'-肌苷酸脱氢酶抑制剂作为新一代抗菌药物的研究进展
Medchemcomm. 2019 May 2;10(8):1290-1301. doi: 10.1039/c9md00179d. eCollection 2019 Aug 1.
8
Horizontal transfer of a pathway for coumarate catabolism unexpectedly inhibits purine nucleotide biosynthesis.意想不到的是，香豆酸分解途径的水平转移会抑制嘌呤核苷酸的生物合成。
Mol Microbiol. 2019 Dec;112(6):1784-1797. doi: 10.1111/mmi.14393. Epub 2019 Oct 1.
9
Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection.鉴定幽门螺杆菌 IMPDH 的选择性抑制剂作为感染的靶向治疗。
Sci Rep. 2019 Jan 17;9(1):190. doi: 10.1038/s41598-018-37490-x.
10
Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.拓展苯并恶唑基肌苷 5′-单磷酸脱氢酶（IMPDH）抑制剂结构-活性关系，开发有潜力的抗结核药物。
J Med Chem. 2018 Jun 14;61(11):4739-4756. doi: 10.1021/acs.jmedchem.7b01839. Epub 2018 May 30.
本文引用的文献
1
Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.微小隐孢子虫肌苷5'-单磷酸脱氢酶的三唑抑制剂
J Med Chem. 2009 Aug 13;52(15):4623-30. doi: 10.1021/jm900410u.
2
IMP dehydrogenase: structure, mechanism, and inhibition.肌苷酸脱氢酶：结构、机制与抑制作用
Chem Rev. 2009 Jul;109(7):2903-28. doi: 10.1021/cr900021w.
3
A kinetic alignment of orthologous inosine-5'-monophosphate dehydrogenases.直系同源肌苷-5'-单磷酸脱氢酶的动力学比对
Biochemistry. 2008 Aug 19;47(33):8689-96. doi: 10.1021/bi800674a. Epub 2008 Jul 22.
4
Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.针对真核病原体中的一种原核蛋白：鉴定抗隐孢子虫病的先导化合物。
Chem Biol. 2008 Jan;15(1):70-7. doi: 10.1016/j.chembiol.2007.12.010.
5
An updated review on Cryptosporidium and Giardia.关于隐孢子虫和贾第虫的最新综述。
Gastroenterol Clin North Am. 2006 Jun;35(2):291-314, viii. doi: 10.1016/j.gtc.2006.03.006.
6
Cryptosporidium: a water-borne zoonotic parasite.隐孢子虫：一种水源性人畜共患寄生虫。
Vet Parasitol. 2004 Dec 9;126(1-2):37-56. doi: 10.1016/j.vetpar.2004.09.004.
7
The genome of Cryptosporidium hominis.人隐孢子虫的基因组。
Nature. 2004 Oct 28;431(7012):1107-12. doi: 10.1038/nature02977.
8
Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.微小隐孢子虫肌苷-5'-单磷酸脱氢酶：可用于药物设计的功能、结构和动力学特性鉴定
J Biol Chem. 2004 Sep 24;279(39):40320-7. doi: 10.1074/jbc.M407121200. Epub 2004 Jul 21.
9
Complete genome sequence of the apicomplexan, Cryptosporidium parvum.顶复门寄生虫微小隐孢子虫的全基因组序列
Science. 2004 Apr 16;304(5669):441-5. doi: 10.1126/science.1094786. Epub 2004 Mar 25.
10
Gene transfer in the evolution of parasite nucleotide biosynthesis.寄生虫核苷酸生物合成进化中的基因转移
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3154-9. doi: 10.1073/pnas.0304686101. Epub 2004 Feb 18.
Zotero 插件